Immunohistochemical tenascin-C expression in paediatric supratentorial glioblastoma multiforme

被引:3
作者
Germanò, A
Galatioto, S
Caffo, M
Caruso, G
La Torre, D
Cardia, E
Tomasello, F
机构
[1] Univ Messina, Sch Med, Neurosurg Clin Policlin, I-98125 Messina, Italy
[2] Univ Messina, Sch Med, Dept Human Pathol, I-98125 Messina, Italy
关键词
angiogenesis; glioblastoma multiforme; immunohistochemistry; tenascin-C;
D O I
10.1007/s003810050531
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tenascin-C (TN-C) plays an important part in the growth of neoplastic tissue, leading to new vessel development. TN-C has been assessed in adult glioblastoma multiforme (GBM) and has been evaluated as anti-neoplastic therapy. No studies have focused on this tissue in paediatric GBM. Tissues were obtained from six paediatric supratentorial GBMs. Immunohistochemistry was performed using a mouse antibody directed against human TN-C, and expression in tumour vasculature was described on the basis of TN-C immunoreactivity. The expression was minimal in three, moderate in two, and intense in one specimen. TN-C was not correlated with clinical history, neurological findings, or with tumour site. Although based on a limited number of patients, this study provides additional insights into tumour growth modulation and cytogenetic profile of paediatric GBM. The detailed understanding of events responsible for GBM growth is a prerequisite for the development of therapeutic modalities leading to improved prognosis and cure.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 27 条
  • [1] INTRALESIONAL ADMINISTRATION OF I-131-LABELED MONOCLONAL-ANTIBODIES IN THE TREATMENT OF MALIGNANT GLIOMAS
    ARISTA, A
    STURIALE, C
    RIVA, P
    TISON, V
    FRATTARELLI, M
    MOSCATELLI, G
    FRANCESCHI, G
    SPINELLI, A
    [J]. ACTA NEUROCHIRURGICA, 1995, 135 (3-4) : 159 - 162
  • [2] SUPRATENTORIAL GLIOBLASTOMA IN CHILDREN - A SERIES OF 27 SURGICALLY TREATED CASES
    ARTICO, M
    CERVONI, L
    CELLI, P
    SALVATI, M
    PALMA, L
    [J]. CHILDS NERVOUS SYSTEM, 1993, 9 (01) : 7 - 9
  • [3] Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results
    Bigner, DD
    Brown, MT
    Friedman, AH
    Coleman, RE
    Akabani, G
    Friedman, HS
    Thorstad, WL
    McLendon, RE
    Bigner, SH
    Zhao, XG
    Pegram, CN
    Wikstrand, CJ
    Herndon, JE
    Vick, NA
    Paleologos, N
    Cokgor, I
    Provenzale, JM
    Zalutsky, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2202 - 2212
  • [4] Bodey B, 1998, ANTICANCER RES, V18, P1485
  • [5] TENASCIN MEDIATES CELL ATTACHMENT THROUGH AN RGD-DEPENDENT RECEPTOR
    BOURDON, MA
    RUOSLAHTI, E
    [J]. JOURNAL OF CELL BIOLOGY, 1989, 108 (03) : 1149 - 1155
  • [6] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS
    BROOKS, PC
    CLARK, RAF
    CHERESH, DA
    [J]. SCIENCE, 1994, 264 (5158) : 569 - 571
  • [7] TENASCIN DISTRIBUTION IN HUMAN BRAIN-TUMORS
    CASTELLANI, P
    DORCARATTO, A
    SIRI, A
    ZARDI, L
    VIALE, GL
    [J]. ACTA NEUROCHIRURGICA, 1995, 136 (1-2) : 44 - 50
  • [8] TENASCINS, A GROWING FAMILY OF EXTRACELLULAR-MATRIX PROTEINS
    CHIQUETEHRISMANN, R
    [J]. EXPERIENTIA, 1995, 51 (9-10): : 853 - 862
  • [9] TENASCIN - AN EXTRACELLULAR-MATRIX PROTEIN PROMINENT IN SPECIALIZED EMBRYONIC-TISSUES AND TUMORS
    ERICKSON, HP
    BOURDON, MA
    [J]. ANNUAL REVIEW OF CELL BIOLOGY, 1989, 5 : 71 - 92
  • [10] ERICKSON HP, 1988, ADV CELL BIOL, V2, P55